Expression of COX-2 in different subtypes of gastric intestinal metaplasia and gastric carcinoma by tissue microarray

Chinese-German Journal of Clinical Oncology

Volumn 4, Issue 3, 2005, Pages 151-154

  Liu, Guisheng ^a   Gong, Jun ^a   Cheng, Peng ^a   Dai, Fei ^a   Zhang, Jun ^a   Chang, Ying ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

Cyclooxygenase 2; Gastric carcinoma; Intestinal metaplasia; Tissue microarray

Indexed keywords

ALCIAN BLUE; CYCLOOXYGENASE 2; EOSIN; HEMATOXYLIN;

ARTICLE; CANCER RISK; CANCER STAGING; CARCINOGENESIS; CHRONIC GASTRITIS; CLINICAL ARTICLE; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; HUMAN; IMMUNOHISTOCHEMISTRY; INTESTINE METAPLASIA; MALIGNANT NEOPLASTIC DISEASE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; RISK ASSESSMENT; STATISTICAL SIGNIFICANCE; STOMACH CARCINOMA; TISSUE MICROARRAY;

EID: 22144489932     PISSN: 16101979     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10330-004-0305-1     Document Type: Article

References (18)

1. Rees BP, Saukkonen K, Ristimäki A, et al. Cyclooxygenase-2 expression during carcinogenesis in the stomach. J Pathol, 2002, 196: 171-179.
2. Walker MM. Cyclooxygenase-2 expression in early gastric cancer, intestinal metaplasia and Helicobacter pylori infection. Eur J Gastroenterol Hepatol, 2002, 14: 347-349.
3. Sung JJ, Leung WK, Go MY, et al. Cyclooxygenase-2 expression in Helicobacter pylori-associated premalignant and malignant gastric lesions. Am J Pathol, 2000, 157: 729-735.
4. El-Zimaity HM, Ramchatesingh J, Saeed MA, et al. Gastric intestinal metaplasia: Subtypes and natural history. J Clin Pathol, 2001, 54:679-683.
5. Bai YQ, Yamamoto H, Akiyama Y, et al. Ectopic expression of homeodomain protein CDX2 in intestinal metaplasia and carcinomas of the stomach. Cancer Lett, 2002, 176: 47-55.
6. Tahara E. Genetic pathways of two types of gastric cancer. IARC Sci Publ, 2004, 157: 327-349.
7. Lauwers GY. Defining the pathologic diagnosis of metaplasia, atrophy, dysplasia, and gastric adenocarcinoma. J Clin Gastroenterol, 2003, 36 (5 Suppl): S37-43; discussion S61-62.
8. Huang GJ, Zhang YL, Le ZQ, et al. The characteristics of gastrin receptor expression in gastric cancer. Chinese-German J Clin Oncol, 2: 145-148.
9. Zeng FJ, Hua ZC, Wang Y. Expression of telomerase activity in gastric cancer cells. Chinese-German J Clin Oncol, 1: 92-93.
10. Wang DX, Fang DC, Liu WW, et al. Study of the loss of heterozygosity at YNZ22 gene and P53 gene alteration in the gastric intestinal metaplasia. Med PLA (Chinese), 2001, 26: 36-38.
11. Leung WK, Sung JJ. Review article: Intestinal metaplasia and gastric carcinogenesis. Aliment Pharmacol Ther, 2002, 16: 1209-1216.
12. Petersson F, Borch K, Franzen LE. Prevalence of subtypes of intestinal metaplasia in the general population and in patients with autoimmune chronic atrophic gastritis. Scand J Gastroenterol, 2002, 37: 262-266.
13. Conchillo JM, Houben G, Bruine A, et al. Is type III intestinal metaplasia an obligatory precancerous lesion in intestinal-type gastric carcinoma? Eur J Cancer Prev, 2001, 10: 307-312.
14. Morris CD, Armstrong GR, Bigley G, et al. Cyclooxygenase-2 expression in the Barrett's metaplasia-dysplasia-adenocarcinoma sequence. Am J Gastroenterol, 2001, 96: 990-996.
15. Piazuelo MB, Haque S, Delgado A, et al. Phenotypic differences between esophageal and gastric intestinal metaplasia. Mod Pathol, 2004, 17: 62-74.
16. Yamagata R, Shimoyama T, Fukuda S, et al. Cyclooxygenase-2 expression is increased in early intestinal-type gastric cancer and gastric mucosa with intestinal metaplasia. Eur J Gastroenterol Hepatol, 2002, 14: 359-363.
17. Joo YE, Oh WT, Rew JS, et al. Cyclooxygenase-2 expression is associated with well-differentiated and intestinal-type pathways in gastric carcinogenesis. Digestion, 2002, 66: 222-229.
18. Yu LZ, Gao HJ, Bai JF, et al. Expression of COX-2 proteins in gastric mucosal lesions. World J Gastroenterol, 2004, 10: 292-294.